Durability of Effect With Long-Term Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension

被引:0
|
作者
Isaacson, Stuart [3 ]
Lisk, Jerome [4 ]
Liang, Grace [2 ]
Rowse, Gerald [1 ]
机构
[1] Lundbeck NA Ltd, Charlotte, NC USA
[2] Neurocrine Biosci Inc, San Diego, CA USA
[3] Parkinsons Dis & Movement Disorders Ctr Boca Rato, Boca Raton, FL USA
[4] Southern Calif Movement Disorder Specialists, Pasadena, CA USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P5.128
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension
    Isaacson, Stuart
    Vernino, Steven
    Ziemann, Adam
    Rowse, Gerald J.
    Kalu, Uwa
    White, William B.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2016, 10 (10) : 755 - 762
  • [2] Durability of effect with long-term, open-label droxidopa treatment in patients with symptomatic neurogenic orthostatic hypotension (NOH 303)
    Isaacson, S.
    Shill, H.
    Vernino, S.
    Cioffi, C.
    Hutchman, R.
    MOVEMENT DISORDERS, 2012, 27 : S424 - S425
  • [3] Use of droxidopa for the long-term treatment of neurogenic orthostatic hypotension
    Raj, Satish R.
    Hewitt, Lawrence Arthur
    EUROPEAN HEART JOURNAL, 2019, 40 (01) : 69 - 70
  • [4] Safety and Durability of Effect with Long-Term, Open-Label Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension (NOH303)
    Isaacson, Stuart
    Shill, Holly A.
    Vernino, Steven
    Ziemann, Adam
    Rowse, Gerald J.
    JOURNAL OF PARKINSONS DISEASE, 2016, 6 (04) : 751 - 759
  • [5] Use of droxidopa for the long-term treatment of neurogenic orthostatic hypotension Reply
    Brignole, Michele
    Fanciulli, Alessandra
    van Dijk, Gert
    EUROPEAN HEART JOURNAL, 2019, 40 (01) : 71 - 71
  • [6] Durability of effect with long-term droxidopa treatment in patients with symptomatic NOH
    Isaacson, S.
    Liang, G.
    Lisk, J. P.
    MOVEMENT DISORDERS, 2015, 30 : S93 - S93
  • [7] Responder Analyses of Droxidopa in Patients with Symptomatic Neurogenic Orthostatic Hypotension
    Rowse, Gerald
    Hewitt, Lawrence
    Shields, Alan
    Freeman, Roy
    Kaufmann, Horacio
    NEUROLOGY, 2016, 86
  • [8] Responder analyses of droxidopa in patients with symptomatic neurogenic orthostatic hypotension
    Rowse, G. J.
    Hewitt, L. A.
    Shields, A.
    Freeman, R.
    Kaufmann, H.
    MOVEMENT DISORDERS, 2015, 30 : S116 - S117
  • [9] Cardiovascular Safety of Droxidopa in Patients With Symptomatic Neurogenic Orthostatic Hypotension
    White, William B.
    Hauser, Robert A.
    Rowse, Gerald J.
    Ziemann, Adam
    Hewitt, L. Arthur
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 119 (07): : 1111 - 1115
  • [10] Long-term Efficacy Of Atomoxetine For The Treatment Of Symptomatic Neurogenic Orthostatic Hypotension
    Urechie, Vasile
    Rigo, Stefano
    Palma, Jose-Alberto
    Diedrich, Andre
    Biaggioni, Italo
    Kaufmann, Horacio
    Shibao, Cyndya A.
    HYPERTENSION, 2022, 79